4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-20-000071
Chief Financial Officer gave up 1,707 shares (to pay taxes)
- Chief Financial Officer acquired 5,753 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Biller Jonathan · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-03 | Exercise or conversion : show line 1 in the form | +5,753 | 11,747 | D | ||
| 2020-12-03 | Shares withheld for taxes : show line 2 in the form | −1,707 | $45.87 | $78,300 | 10,040 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-12-03 | Exercise or conversion : show line 3 in the form Restricted stock units | −5,753 | 11,506 | D |
Loading xslF345X03/wf-form4_160738329299398.xml…